Litcius/Paper detail

Crizanlizumab: First Approval

Hannah A. Blair

2020Drugs65 citationsDOI

Topics & Concepts

MedicineRuxolitinibDrug approvalDiseaseSickle cell anemiaMyelofibrosisPharmacotherapyDrugInternal medicinePharmacologyBone marrowHemoglobinopathies and Related DisordersMyeloproliferative Neoplasms: Diagnosis and TreatmentIron Metabolism and Disorders
Crizanlizumab: First Approval | Litcius